Aurobindo Pharma shares tumble nearly 7% in early trade, hit 52-week low after Q2 earnings

Aurobindo Pharma on Saturday reported a 41 per cent decline in its consolidated net profit at Rs 409 crore for the second quarter ended September 30, 2022.